2018
DOI: 10.1128/aac.00079-18
|View full text |Cite
|
Sign up to set email alerts
|

Leishmania donovani Parasites Are Inhibited by the Benzoxaborole AN2690 Targeting Leucyl-tRNA Synthetase

Abstract: Visceral leishmaniasis is an important public health threat in parts of India. It is caused by a protozoan parasite, Currently available drugs manifest severe side effects. Hence, there is a need to identify new drug targets and drugs. Aminoacyl-tRNA synthetases, required for protein synthesis, are known drug targets for bacterial and fungal pathogens. The aim of the present study was to obtain essentiality data for leucyl-tRNA synthetase (LRS) by gene replacement. Gene replacement studies indicate that this e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
22
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(22 citation statements)
references
References 43 publications
0
22
0
Order By: Relevance
“…Compound 89 (C89) is a kind of benzoborazole. C89, 7-formyl-1,3-dihydro-1-hydroxy-2,1-benzoxaborole, was recently synthesized based on the structure of AN2690 [33,34], 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole, an antifungal agent that inactivates fungalleucyl-tRNA synthetase [35]. C89 is a novel compound, and have been no reports about the function of C89 in the autophagy of FGSCs or other kinds of cells.…”
Section: Introductionmentioning
confidence: 99%
“…Compound 89 (C89) is a kind of benzoborazole. C89, 7-formyl-1,3-dihydro-1-hydroxy-2,1-benzoxaborole, was recently synthesized based on the structure of AN2690 [33,34], 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole, an antifungal agent that inactivates fungalleucyl-tRNA synthetase [35]. C89 is a novel compound, and have been no reports about the function of C89 in the autophagy of FGSCs or other kinds of cells.…”
Section: Introductionmentioning
confidence: 99%
“…In a new drug screening process, leucyl-tRNA synthetase from L. donovani ( Ld LRS) was selected as a potential drug target for Leishmania . This enzyme plays an essential role in the viability of this pathogenic organism and appears to be indispensable for its survival in vitro [ 112 ]. Compound 2 ( Figure 1 ) exhibited anti-leishmanial activity against both promastigote and amastigote stages, in vitro, as well as in vivo in BALB/c mice, as shown in Figure 13 A.…”
Section: Neglected Tropical Diseases (Ntd)mentioning
confidence: 99%
“…The weight of the spleen was measured and dabbed imprints on glass slides were made, followed by fixation with 100% methanol and Giemsa staining. Infection was monitored microscopically by using Giemsa-stained imprints, in which parasite burdens were measured by counting the numbers of amastigotes per 500 spleen nuclei and multiplying by the spleen weight (mg) (Leishman-Donovan units [LDU]) (81). The results for the treated and untreated groups were compared.…”
Section: Sds-page and Western Blottingmentioning
confidence: 99%